UHS delivered solid performance in Q2 2025, driven by higher Medicaid reimbursements and growth across both acute and behavioral health segments.
Reported revenue rose to $4.28B, up from $3.91B in Q2 2024.
Net income increased to $353.2M, with EPS at $5.43.
Acute care and behavioral health both saw revenue and patient day growth.
Strong cash position with $137.6M in cash and equivalents at quarter end.
UHS raised its full-year 2025 forecast for revenue, adjusted EPS, and adjusted EBITDA due to improved Medicaid reimbursements and strong performance in core operations.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance